High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$2.0M
$2,037,994
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
LGND
S
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
10b5-1 Sell
2026-04-01
$1,006,224Largex6
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
10b5-1 Sell
|
2026-04-01 | $1,006,224Largex6 | S | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
10b5-1 Sell
2026-03-04
$1,031,770Largex11
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
10b5-1 Sell
|
2026-03-04 | $1,031,770Largex11 | S | Form 4 |